Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.2.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
 [1]
Current Assets:    
Cash and cash equivalents $ 27,124 $ 30,014
Restricted cash 1,287 15,466
Accounts receivable, net (net of allowance for credit losses of $26 and $85, respectively) 64,081 58,729
Inventories 49,434 52,611
Derivative instruments 5,606 2,412
Other current assets 6,126 9,538
Total current assets 153,658 168,770
Property and equipment, net 244,893 248,748
Other Assets:    
Right of use operating lease assets, net 20,404 22,597
Intangible assets, net 8,204 8,498
Other assets 5,339 5,628
Total other assets 33,947 36,723
Total Assets 432,498 454,241
Current Liabilities:    
Accounts payable 20,132 20,752
Accrued liabilities 16,504 20,205
Current portion – operating leases 4,481 4,333
Derivative instruments 2,764 13,849
Other current liabilities 5,886 6,149
Total current liabilities 49,767 65,288
Long-term debt, net 90,960 82,097
Operating leases, net of current portion 16,828 19,029
Other liabilities 9,120 8,270
Total Liabilities 166,675 174,684
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2024 and December 31, 2023; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2024 and December 31, 2023; liquidation preference of $18,075 as of June 30, 2024 1 1
Common stock, value 77 76
Additional paid-in capital 1,042,639 1,040,912
Accumulated other comprehensive income 2,481 2,481
Accumulated deficit (779,375) (763,913)
Total stockholders’ equity 265,823 279,557
Total Liabilities and Stockholders’ Equity 432,498 454,241
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2023.